Sensulin™ is seeking partners to commercialize its insulin platform, but also its stimulus-responsive drug delivery system. We can encapsulate many types of therapeutics in our liposomes, and trigger release upon a variety of stimuli. Please see our R&D for peer-reviewed publications that demostrate the versatility of our platform.

If a collaboration would be of interest, please contact our CEO Mike Moradi.